Santhera Pharmaceuticals Holding AG (LON:0QN1)
9.87
+0.20 (2.11%)
At close: Oct 15, 2025
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 79 employees as of December 31, 2024. The number of employees increased by 34 or 75.22% compared to the previous year.
Employees
79
Change (1Y)
34
Growth (1Y)
75.22%
Revenue / Employee
569.45K GBP
Profits / Employee
-761.45K GBP
Market Cap
128.35M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 79 | 34 | 75.22% |
Dec 31, 2023 | 45 | -1 | -2.18% |
Dec 31, 2022 | 46 | 6 | 16.24% |
Dec 31, 2021 | 39 | -47 | -54.19% |
Dec 31, 2020 | 86 | -27 | -23.83% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
Spire Healthcare Group | 15,703 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
Genus | 3,190 |
Santhera Pharmaceuticals Holding AG News
- 13 days ago - Santhera Partners With Biomedica To Distribute Agamree In Russia - Nasdaq
- 19 days ago - Health Canada Approves Santhera's AGAMREE For Duchenne Muscular Dystrophy - Nasdaq
- 23 days ago - Santhera Pharmaceuticals Holding AG (SPHDF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Santhera Pharmaceuticals Holding AG 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Santhera Pharma Stock Down On Wider H1 Loss; Is AGAMREE On Track? - Nasdaq
- 7 weeks ago - Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE® (Vamorolone) in India - GlobeNewsWire
- 2 months ago - Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries - GlobeNewsWire
- 6 months ago - Santhera Pharmaceuticals reports FY results - Seeking Alpha